Oral NSAIDs are a mainstay for the treatment of low back pain, osteoarthritis, and other acute and chronic musculoskeletal complaints. However, concern for side effects like GI bleeding, GI upset, and nephropathy limit their use. Topical NSAIDs can provide many of the same benefits as oral NSAIDs, with potentially fewer risks.
Initial studies suggest that pediatric exposures are up, but adverse effects are low
Before you travel abroad this summer, familiarize yourself with the ins and outs of Ciprofloxacin. Plus: Which popular travel destinations have tap water that is safe to drink? Take the quiz… then pack accordingly.
The drug of Summer in the Southeast
Emergency medicine is dangerous work. Here’s a rundown of some of the greatest infection threats and their appropriate prophylactic agents
A target-specific oral anti-coagulant, dabigatran/Pradaxa™ proves that Warfarin isn’t the only game in town.
This fundamental building block of life will stop your heart — just long enough to be useful
Flu season is upon us. The decision to treat with a neuraminidase inhibitor requires a risk-benefit analysis, and for many patients, the risks of side effects and the cost may outweigh the potential benefits. A 2014 Cochrane review was finally able to evaluate previously unavailable data, and found neuraminidase inhibitors are not all we had hoped.
Class A morning sickness medication gains FDA approval after decades of being misunderstood
In this case study, a single administration of methylene blue resolved significant amyl nitrate intoxication and critical methemoglobinemia.